GE HealthCare GEHC

Medical imaging equipment. GE HealthCare Technologies Inc., listed on NASDAQ.

Based on the FY2025 annual report (Jan 2025 – Dec 2025)

GE HealthCare's market cap is
about $38.11 billion.

#258 by market cap among 289 companies, based on the Nov 5, 2026 close. FY2025 revenue was $20.625B.

Share price (close): $83.75; Close on Nov 5, 2026 · per share
P/E ratio: 18.4x; Closing price ÷ latest annual EPS
Market cap: $38.11B; #258 of 289
Revenue: $20.625B; #155 of 299 · +4.8% YoY
Operating income: $2.763B; #133 of 231 · +5.3% YoY
Net income: $2.084B; #182 of 298 · +4.6% YoY
Free cash flow: $1.505B; #189 of 261 · −3.2% YoY
Total assets: $36.906B; #181 of 299 · +11.5% YoY
Dividends paid: $64M; #209 of 214 · +16.4% YoY
Dividend per share: $0.14; #202 of 205 · +12.0% YoY
Dividend yield: 0.2%; #194 of 203
Shares outstanding: 458,000,000 shares; As of Dec 31, 2025

Size, put in perspective

Revenue every second$654$56.5M a day

Net income every second$66$5.71M a day

Buying ResMed with a year's profit6.2% of itBased on ResMed's market cap of about $33.66 billion

Market cap vs ResMed1.1×GE HealthCare ÷ ResMed

Calculated from the FY2025 annual report, spread evenly over 365 days.

Where the revenue went

Revenue is set at 100% and split into what went to costs, R&D, operating expenses and taxes, and what was left as profit.

R&D6.1%
SG&A and other80.5%
Taxes, interest & other3.3%
Net income10.1%

Profitability and stability

Each figure comes with its rank among 300 companies. The further right the dot, the higher the rank.

Revenue growthHow much revenue grew from the previous fiscal year: +4.8%; #202 of 299; Revenue was roughly flat. The median across 299 companies is +7.9%.
Operating marginShare of revenue kept as profit from the core business: 13.4%; #151 of 231; 13.4% of revenue was kept as operating profit, which is on the low side. The median across 231 companies is 19.2%.
Net marginShare of revenue left as profit after interest and taxes: 10.1%; #203 of 298; After taxes, 10.1% of revenue was left as net income. The median across 298 companies is 14.0%.
FCF marginShare of revenue left as cash after capital spending: 7.3%; #197 of 261; Cash is left over after capital spending. The median across 261 companies is 15.8%.
ROEHow much profit the company earned on shareholders' equity in a year: 22.1%; #112 of 276; Earns a lot relative to its equity. The median across 276 companies is 16.8%.
Debt-to-equityLiabilities relative to equity. Lower means less debt: 253.5%; #168 of 244; Liabilities are more than twice equity. The median across 244 companies is 159.6%.

Revenue and profit over time

Gray bars show revenue and the green part inside shows net income. The number above each bar is revenue (abbreviated) and the number below is net margin. Hover over a bar to see the exact amounts.

Currency: US dollars. Years are the years in which each fiscal year ended.

Where the cash went

Unlike profit, cash flow is money that actually came in and went out.

Cash from operations$1.987B
Capital spending−$482M
Free cash flow (FCF)$1.505B
Dividends paid−$64M

Whose money funds the assets

The company's assets, split into borrowed money (liabilities) and shareholders' money (equity).

Liabilities 71%Equity 28%

Total assets$36.906B
Total liabilities$26.307B
Total equity$10.379B
Cash and equivalents$4.492B

Compared with similar companies

Based on each company's latest annual report, so fiscal year ends may differ.

Compare in detail

Company	Annual revenue	Net income	Revenue growth	Operating margin	Net margin
GE HealthCareGEHC	$20.625B	$2.084B	+4.8%	13.4%	10.1%
ResMedRMD	$5.653443B	$1.523293B	+9.8%	33.4%	26.9%
IDEXX LaboratoriesIDXX	$4.303702B	$1.059464B	+10.4%	31.6%	24.6%
Edwards LifesciencesEW	$6.0676B	$1.0735B	+11.6%	20.8%	17.7%
Becton DickinsonBDX	$21.84B	$1.678B	+8.2%	11.8%	7.7%

What the company does

GE HealthCare makes CT, MRI and ultrasound imaging equipment and contrast agents. It was spun off from GE in 2023.

The fiscal year ends around December each year.

Financial statements

Last 5 fiscal years. Currency: US dollars.

Show the table

Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	17.585B	18.341B	19.552B	19.672B	20.625B
Gross profit	7.174B	7.179B	7.922B	8.205B	8.248B
R&D expense	816M	1.026B	1.205B	1.311B	1.26B
Operating income	2.795B	2.522B	2.435B	2.625B	2.763B
Pretax income	2.875B	2.512B	2.361B	2.581B	2.768B
Net income	2.247B	1.916B	1.568B	1.993B	2.084B
EPS (diluted)	$4.95	$4.22	$3.03	$4.34	$4.55
Operating cash flow	1.607B	2.134B	2.101B	1.955B	1.987B
Capital expenditures	248M	310M	387M	401M	482M
Free cash flow (FCF)	1.359B	1.824B	1.714B	1.554B	1.505B
Dividends paid	0	0	41M	55M	64M
Total assets	—	27.539B	32.454B	33.089B	36.906B
Total liabilities	—	17.947B	25.144B	24.437B	26.307B
Total equity	16.676B	9.362B	7.145B	8.446B	10.379B
Cash and equivalents	561M	1.451B	2.506B	2.874B	4.492B
Original filing	10-K	10-K	10-K	10-K	10-K

Source: SEC EDGAR filings for GE HealthCare Technologies Inc. · CIK 0001932393 · US-GAAP